Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST8SIA5 divergent transcript (ST8SIA5-DT) is a long non-coding RNA (lncRNA) gene located near the ST8SIA5 gene in the human genome, classified as a divergent transcript according to the HUGO Gene Nomenclature Committee. Divergent transcripts are typically defined as non-coding RNAs within 300–500 nucleotides of a protein-coding gene, often transcribed from the opposite strand. There is currently no evidence that ST8SIA5-DT encodes a protein, acts as a canonical therapeutic target (receptor, enzyme, transporter, etc.), or has validated roles in disease or drug interaction in major biomedical databases[5][6][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ST8SIA5 divergent transcript (ST8SIA5-DT).